3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
6
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
2
Vulvar Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Stomach Neoplasms
1
Soft Tissue Neoplasms
1
Skull Base Neoplasms
1
Rectal Neoplasms
1
Neovascularization, Pathologic
1
Neoplasms
1
Intracranial Arteriovenous Malformations
1
Intracranial Aneurysm
1
Hypoparathyroidism
1
Colorectal Cancer Metastatic
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Bone Neoplasms
1
Interventions
Sorafenib
20
lenvatinib
18
Hepatectomy
17
Blood Specimen Collection
12
Immune Checkpoint Inhibitors
11
atezolizumab
9
Liver Transplantation
9
Surgical Procedures, Operative
7
Radiofrequency Ablation
7
Observation
7
Bevacizumab
7
regorafenib
5
gadolinium ethoxybenzyl DTPA
5
sintilimab
4
donafenib
4
camrelizumab
4
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
tislelizumab
3
spartalizumab
3
Polymerase Chain Reaction
3
Neoadjuvant Therapy
3
Mass Spectrometry
3
Immunohistochemistry
3
Doxorubicin
3
Angiogenesis Inhibitors
3
toripalimab
2
pembrolizumab
2
entecavir
2
apatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Carcinoma, Hepatocellular
×
Indocyanine Green
×
Clear all
NCT02967848
2026-02-05
LiverINSPECT
Royal North Shore Hospital
Active not recruiting
20 enrolled